Skip to main content
. Author manuscript; available in PMC: 2014 Jun 6.
Published in final edited form as: J Allergy Clin Immunol. 2014 May;133(5):1289–130112. doi: 10.1016/j.jaci.2014.02.006

TABLE I.

Distribution of traits across clusters

AOE classification Cluster 1 (n = 300)
Cluster 2 (n = 202)
Cluster 3 (n = 218)
Cluster 4 (n = 225)
Cluster 5 (n = 96)
LLL HLL HHM MHH HHH
Asthma history

 Age of asthma onset (y) 3.52 ± 2.63 3.09 ± 2.40 3.66 ± 2.62 2.21 ± 1.89 2.27 ± 1.80

 No. of subjects ever hospitalized for asthma (%) 0 (0) 0 (0) 1 (0.46) 225 (100) 94 (97.9)

 ED visits for asthma (no./100 person-years) 44.3 47.0 70.2 75.6 101

Atopic features

 History of AD (%) 0 (0) 202 (100) 2 (0.1) 0 (0) 94 (97.9)

 History of hay fever (%) 61 (20.3) 132 (65.3) 191 (87.6) 119 (52.9) 54 (56.3)

 History of positive skin test responses (%) 230 (76.7) 185 (91.6) 209 (95.9) 198 (88) 92 (95.8)

 Total serum IgE levels (log10) 2.37 ± 0.70 2.72 ± 0.72 2.79 ± 0.58 2.64 ± 0.61 2.81 ± 0.63

Spirometry

 Prebronchodilator FEV1 (% predicted) 96.4 ± 12.7 97.7 ± 14.8 89.7 ± 13.9 91.4 ± 13.8 92.0 ± 16.1

 Prebronchodilator FEV1/FVC (% predicted) 81.8 ± 7.68 81.5 ± 7.59 77.6 ± 8.54 77.8 ± 8.24 78.6 ± 9.60

 Prebronchodilator peak flow 276.1 ± 67.3 274.3 ± 73.3 276.7 ± 69.1 276.4 ± 70.8 255.6 ± 73.3

Airway responsiveness

 Methacholine PC20 (natural log) 0.71 ± 1.03 0.14 ± 1.11 −0.54 ± 1.00 0.038 ± 1.14 −0.23 ± 1.17

 FEV1 bronchodilator response (L) 0.077 ± 0.07 0.097 ± 0.08 0.12 ± 0.11 0.12 ± 0.11 0.16 ± 0.14

Anthropomorphic features

 BMI (kg/m2) 18.1 ± 3.46 18.6 ± 3.83 18.5 ± 3.66 17.8 ± 3.19 17.6 ± 3.38

 Waist/hip ratio 0.882 ± 0.06 0.885 ± 0.07 0.881 ± 0.06 0.874 ± 0.05 0.877 ± 0.07

Peripheral blood counts

 Eosinophils (log10) 2.35 ± 0.55 2.54 ± 0.53 2.57 ± 0.52 2.50 ± 0.49 2.71 ± 0.41

 Lymphocytes (%) 42.1 ± 11.5 40.9 ± 9.82 41.1 ± 10.9 41.7 ± 10.5 40.8 ± 9.78

 Neutrophils (%) 45.5 ± 12.2 44.5 ± 11.0 44.6 ± 11.5 44.7 ± 11.5 43.1 ± 11.0